Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Accumulated Expenses (2016 - 2025)

Amdocs (DOX) has disclosed Accumulated Expenses for 14 consecutive years, with $207.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses fell 73.39% to $207.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $207.3 million, a 73.39% decrease, with the full-year FY2025 number at $207.3 million, down 73.39% from a year prior.
  • Accumulated Expenses was $207.3 million for Q3 2025 at Amdocs, down from $778.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $778.9 million in Q3 2024 to a low of $207.3 million in Q3 2025.
  • A 5-year average of $501.6 million and a median of $612.7 million in 2022 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: soared 123.37% in 2022, then tumbled 73.39% in 2025.
  • Amdocs' Accumulated Expenses stood at $274.3 million in 2021, then soared by 123.37% to $612.7 million in 2022, then grew by 3.6% to $634.7 million in 2023, then grew by 22.72% to $778.9 million in 2024, then crashed by 73.39% to $207.3 million in 2025.
  • Per Business Quant, the three most recent readings for DOX's Accumulated Expenses are $207.3 million (Q3 2025), $778.9 million (Q3 2024), and $634.7 million (Q3 2023).